AKCEA THERAPEUTICS, INC. (AKCA) [Rocket]

In millions, except per share items	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	S-1/A
Total revenues	488.5	64.9	43.4	0.0	0.0	0.0
Revenue growth	653.1%	49.5%
Cost of goods sold	5.7	2.7	0.0	0.0	0.0	0.0
Gross profit	482.9	62.2	43.4	0.0	0.0	0.0
Gross margin	98.8%	95.8%	100.0%
Selling, general and administrative [+]	181.7	153.6	37.0	15.1	10.6	1.0
General and administrative					10.6	1.0
Research and development	292.9	130.3	126.9	68.5	50.9	29.0
Other operating expenses	-29.8	9.0
EBITDA [+]	44.7	-227.6	-120.2	-83.4
EBITDA growth	-119.6%	89.3%	44.2%	36.0%	104.2%
EBITDA margin	9.2%	-350.9%	-277.0%
Depreciation	0.8	0.3	0.1	0.0
EBITA	43.9	-227.9	-120.4	-83.4	-61.3	-30.0
EBITA margin	9.0%	-351.4%	-277.3%
Amortization of intangibles	5.9	2.9	0.1	0.1	0.1
EBIT [+]	38.1	-230.8	-120.5	-83.5	-61.4	-30.0
EBIT growth	-116.5%	91.6%	44.3%	35.9%	104.6%
EBIT margin	7.8%	-355.8%	-277.6%
Interest income, net [+]	5.5	5.6	3.5	0.3	0.0
Interest expense			-1.7
Interest income	5.5	5.6	1.8	0.3	0.0
Other income (expense), net [+]	-0.6	-0.2	-3.4
Other	-0.6	-0.2	0.1
Pre-tax income	43.0	-225.4	-120.3	-83.2	-61.4	-30.0
Income taxes	2.2	0.4	1.3	0.0	0.0	0.0
Tax rate	5.1%			0.0%	0.0%	0.0%
Net income	40.8	-225.8	-121.6	-83.2	-61.4	-30.0
Net margin	8.3%	-348.1%	-280.1%

Basic EPS [+]	$0.43	($2.78)	($7.72)	($2.88)	($2.13)
Growth	-115.4%	-64.0%	167.9%	35.5%
Diluted EPS [+]	$0.43	($2.78)	($4.02)	($1.44)	($2.13)
Growth	-115.4%	-30.9%	178.8%	-32.3%

Shares outstanding (basic) [+]	95.4	81.4	15.7	28.9	28.9
Growth	17.2%	416.7%	-45.5%	0.0%
Shares outstanding (diluted) [+]	95.4	81.4	30.3	57.8	28.9
Growth	17.2%	168.9%	-47.6%	100.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.